Thermo Fisher Scientific
In Brief This Week: Personalis, Cytek, Interpace, Co-Diagnostics, Thermo Fisher, Bruker, More
News items for the week of Aug. 5, 2024.
FDA Approves Thermo Fisher Scientific HLA Typing Kit as CDx for Adaptimmune T-Cell Receptor Therapy
Adaptimmune's therapy is intended to treat patients with unresectable or metastatic synovial sarcoma who have received prior chemotherapy.
New Products Posted to GenomeWeb: Thermo Fisher, Ansa Biotechnologies, Cytek Biosciences, Sengenics
New products and services recently posted on GenomeWeb.
Allelica, Thermo Fisher Integrate Polygenic Risk Score Software Into Axiom Genotyping Arrays
The companies will combine Allelica's PRS software with Thermo Fisher's Axiom human genotyping arrays for end-to-end PRS workflows.
Thermo Fisher Scientific Q2 Revenues Dip 1 Percent, Firm Raises Full-Year 2024 Guidance
The company booked $10.54 billion in total revenues, beating Wall Street expectations and prompting the firm to raise the low end of its full-year 2024 revenue guidance.